//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Cell biologist interested in stem cells, cell plasticity, resilience, adapting and regeneration. 📍 University of Bergen, Norway 👩🏻‍🎓 University of Geneva, Switzerland 🇷🇴🇨🇭🇳🇴
Luiza Ghila









Loading...
Excellent work 👏 by @unger-lucas.bsky.social explaining his work in under 2 minutes movie:
10d
Luiza Ghila
Today I'm posting a new blog about an astonishing scientific own goal. Hundreds of papers have reported using a totally wrong antibody to investigate the tumor suppressor p16. This mistake has happened because scientists have muddled the names of two proteins. forbetterscience.com/2026/06/02/m...
13d
Many thanks 🙏 to Julie Warin and @anne-grapin.bsky.social for a very nice outlook on our paper in @genesdev.bsky.social genesdev.cshlp.org/content/earl...
24d
Sholto David
Simona Chera & Cell Fate Lab
Mount Fuji from space.
26d
Happy to share our work on characterizing pancreas adaptations during pregnancy in the pig. Our pig cohort allowed us to stratify between early and late pregnancy samples in a model resembling the human pregnancy in terms of gestation time and metabolism. www.biorxiv.org/content/10.6... #PancSky
🆕 ADVANCE ONLINE 🆕 RESEARCH PAPER: Defective HNF1A hinders GLI3 processing favoring duodenal versus pancreatic fate, thus leading to intestinal elongation in vivo By Unger et al. Luiza Ghila, and Simona Chera ➡️ https://ow.ly/8oTf50YVMEt Simona Chera & Cell Fate Lab‬ Lucas Unger Luiza Ghila
25d
@sholtodavid.bsky.social Have you seen this WB from ThermoFisher? Still anti-p53 antibody, but another clone (MA-12648 instead MA5-12557). It also looks like that the band in lane 3 was rotated and reused in lane 4. Moreover, it seems that same band was used for the 2 different clones.
Great paper on developmental gene expression patterns underlying species-specific cortical features (with a nice combination of tools and datasets) By @itsmeawais.bsky.social @estherkli.bsky.social @djabaudon.bsky.social @silvianeuro.bsky.social @mveronicapravata.bsky.social and colleagues 🧪🧠🧬
Marthe Gautier est à l’origine de la découverte du chromosome surnuméraire de la trisomie 21, anomalie génétique qui touche 50 000 personnes en France. À l’occasion de la Journée mondiale de la trisomie 21, retour sur le parcours de cette scientifique invisibilisée, avec la biologiste Julie Batut.
25d
Gary Buckley
😀 see also www.nature.com/articles/s41...
24d
26d
2mo
1mo
Christos Karampelias
www.biorxiv.org
📽️ G&D Tapes 📽️ G&D Author, Lucas Unger, tells us about an auto-regulatory loop between HNF1A and Hedgehog signaling that dictates stem cell lineage specification. New in #genesdev: ➡️ https://genesdev.cshlp.org/content/40/11-12/805.full Simona Chera & Cell Fate Lab‬ Lucas Unger Luiza Ghila
Genes & Development
Johan Duchêne
lejournal.cnrs.fr
Marthe Gautier, découvreuse oubliée du chromosome de la trisomie 21
Cedric Boeckx
CNRS
10d
Machine learning analysis of cell-type-specific gene expression in mouse and human neocortex and human cortical organoids reveals human-specific cell-type and temporal variations in expression control...
www.nature.com
Video
Developmental gene expression patterns driving species-specific cortical features - Nature
Cas12a2 enables RNA-triggered, sequence-specific killing of eukaryotic cells via widespread DNA shredding, allowing selective elimination of cells on the basis of gene expression, including virus-infe...
www.nature.com
RNA-triggered cell killing with CRISPR–Cas12a2 - Nature
Alexis Verger 🧬🧫🧪
Genes & Development
New pre-print 📣 “Undruggable” cancer mutations remain very hard to target with current modalities. What if we could instead sense mutant transcripts and convert that recognition into selective cell killing? Check out this work led by postdoc Jingkun Zeng: www.biorxiv.org/content/10.6...
1mo
www.biorxiv.org
Doudna Lab